Cannabis Policy Shift Explained – Per NY Times
The cannabis rescheduling Trump policy is reshaping industry economics. Tax relief and investment may increase. But clinical care and evidence remain largely unchanged.
Cannabis Europa Returns to London with Patient Issues on the Agenda
Cannabis patient advocacy initiatives are gaining prominence at Cannabis Europa in London. These initiatives emphasize patient-centered approaches to cannabis medicine development. They aim to improve clinical access and address real-world challenges in…
Hot Picks: Cannabis consolidation and global demand fuel sector outlook
The cannabis sector outlook 2026 highlights key trends in market consolidation and global demand shaping the industry. These developments influence medical cannabis product quality and research funding. Understanding this outlook is essential for…
Young Americans need to travel abroad to learn what our generation had to deal with to get barely 3gs
“My parents walked uphill both ways in a blizzard just to find a consistent supply.” Modern dispensary: “Would you like our third-party lab results, potency analysis, and a loyalty card with your order?” Via r/trees Further…
Target Expands Role in Hemp THC Drinks Market with New Licenses
Target's involvement in the hemp thc drinks market expansion is marked by 72 new licenses in Minnesota. This development highlights important regulatory and clinical relevance in cannabis medicine. Clinicians should monitor these changes closely for…
The Hemp Industry Is Being Killed By Market Consolidation Disguised As Consumer Protection
Market consolidation hemp industry trends are reshaping the landscape and threatening smaller players. This consolidation is often disguised as consumer protection but has broader implications. Clinicians and industry watchers should monitor these…
MMJ International Holdings Seeks Injunction to Halt CMS CBD Program | Newswire
MMJ International Holdings has filed for a cms cbd program injunction to block a Centers for Medicare and Medicaid Services initiative. This legal action raises critical questions about regulatory oversight of cannabidiol products in Medicare. The…
High Tide to Present at Several Major International Cannabis and Investor Conferences
Corporate cannabis conference presentations highlight industry maturation and investor interest. These events primarily serve commercial stakeholders rather than advancing clinical evidence. Understanding corporate cannabis conference presentations helps…
Analyzing Free Cash Flow Metrics for Cannabis Strategic Ventures
Cannabis company financial metrics like free cash flow per share provide insight into cash generation relative to shares. This metric is key for investors analyzing Cannabis Strategic Ventures. However, these financial metrics do not impact clinical…
Bloom Enters Pennsylvania Medical Cannabis Market With Cresco – MyChesCo
Bloom's entry into the Pennsylvania medical cannabis market with Cresco is a notable development in cannabis medicine. Clinicians should monitor emerging evidence related to this market expansion. This update highlights important clinical relevance for…